WallStSmart
LUNG

Pulmonx Corp

NASDAQ: LUNG · HEALTHCARE · MEDICAL DEVICES

$1.28
+6.67% today

Updated 2026-04-30

Market cap
$54.06M
P/E ratio
P/S ratio
0.60x
EPS (TTM)
$-1.34
Dividend yield
52W range
$1 – $5
Volume
0.6M

Pulmonx Corp (LUNG) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2013201420152016201720182019202020212022202320242025
Revenue$115000.00$332005.00$19450.00$8800.00$0.00$20.00M$32.59M$32.73M$48.42M$53.66M$68.67M$83.79M$90.50M
Revenue growth (YoY)+188.7%-94.1%-54.8%-100.0%+62.9%+0.4%+47.9%+10.8%+28.0%+22.0%+8.0%
Cost of revenue$0.00$48824.00$15563.00$10193.00$0.00$7.72M$10.18M$11.53M$12.79M$13.80M$17.92M$21.79M$23.36M
Gross profit$115000.00$283181.00$3887.00$-1393.00$0.00$12.29M$22.41M$21.20M$35.63M$39.87M$50.75M$62.00M$67.14M
Gross margin100.0%85.3%20.0%-15.8%61.4%68.8%64.8%73.6%74.3%73.9%74.0%74.2%
R&D$798386.00$610199.00$1.25M$1.22M$1.63M$6.99M$6.05M$7.46M$13.06M$15.40M$18.08M$17.57M$19.49M
SG&A$258954.00$1.39M$1.26M$1.29M$3.62M$20.35M$33.60M$44.57M$64.77M$77.00M$89.81M$94.23M$101.31M
Operating income$-942340.00$-1.72M$-2.50M$-2.51M$-5.25M$-15.05M$-17.84M$-32.33M$-47.30M$-58.64M$-61.94M$-57.70M$-53.66M
Operating margin-819.4%-517.2%-12876.1%-28517.5%-75.2%-54.7%-98.8%-97.7%-109.3%-90.2%-68.9%-59.3%
EBITDA$-15.68M$-16.82M$-28.44M$-46.62M$-55.99M$-55.09M$-50.79M$-52.61M
EBITDA margin0.0%0.0%0.0%0.0%-78.4%-51.6%-86.9%-96.3%-104.3%-80.2%-60.6%-58.1%
EBIT$-942340.00$-1.72M$-2.53M$-2.51M$-5.25M$-15.95M$-18.02M$-28.84M$-47.49M$-57.50M$-57.04M$-52.39M$-53.66M
Interest expense$0.00$0.00$0.00$0.00$0.00$2.52M$2.32M$3.18M$829000.00$1.07M$3.23M$3.51M$3.15M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.23M$-1.92M$-2.80M$-2.78M$-5.37M$-18.48M$-20.70M$-32.23M$-48.66M$-58.92M$-60.84M$-56.39M$-54.00M
Net income growth (YoY)-56.0%-45.6%+0.9%-93.5%-244.2%-12.0%-55.7%-51.0%-21.1%-3.3%+7.3%+4.2%
Profit margin-1072.1%-579.4%-14398.3%-31539.3%-92.4%-63.5%-98.5%-100.5%-109.8%-88.6%-67.3%-59.7%